The levels of pro-NAG-1 were increased by sulindac sulfide or quercetin, a conventional NSAID and a phytochemical, respectively; these have been reported to increase pro-NAG-1 levels and exert anticancer activity in several cancers [44,45]. This evidence concerns the gene GDF15 and cancer.